Study on antiangiogenic transformation medicine of advanced colorectal cancer based on APE1 expression

ABSTRACT: Interventions: Experimental group:Endostar combined with FOLFOX;Control group:FOLFOX Primary outcome(s): PFS;ORR Study Design: Randomized parallel controlled trial

DISEASE(S): Colorectal Cancer

PROVIDER: 2676267 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR